Protocol Ledger

NCT06435156 · Phase II · RECRUITING

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

Interventional Phase II clinical trial protocol NCT06435156 sponsored by University of Dundee in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-01-28 Enrollment: 320 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06435156
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)320 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06435156
Protocol FieldVerified Registry Value
NCT IdentifierNCT06435156
Consolidated Lead SponsorUniversity of Dundee
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment320 participants (ESTIMATED)
Registered Start Date2025-01-28
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06435156
Hospital Research SiteLocationSite Profile
Guy's HospitalLondon, United KingdomOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI